Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.’s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

WHAT'S NEW

  • RFK Jr.'s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jun 25 2025

Full Issue

International Doctors Can't Start Medical Residencies Due To Visa Woes

Hundreds of foreign doctors find themselves in limbo just days from when they should be starting their medical residencies at U.S. hospitals. In other news: States sue the Trump administration over grant cuts; Colorado is buying overdose reversal kits; and more.

NBC News: Hundreds Of International Doctors Due To Start Medical Residencies Are In Visa Limbo

A week before they are due to start work at U.S. hospitals, hundreds of doctors from abroad are still waiting to obtain visas granting them temporary stays in the country. Many of them have been in limbo since late May, when the State Department suspended applications for J-1 visas, which allow people to come to the U.S. for exchange visitor programs. The visas are the most common way for international doctors to attend residencies in the U.S., which provide medical graduates with training in a given specialty. (Bendix, McLaughlin and Berk, 6/24)

On federal research and funding cuts —

Bloomberg: States Step Up Fight With Trump Administration On Grant Cuts

Nearly two dozen US states sued the Trump administration to stop it from using what they say is a budget loophole to cut billions of dollars in federal grants that were already approved by Congress. The lawsuit, filed Tuesday, claims the administration is illegally using an Office of Management and Budget spending clause as a “limitless authority to cut grant funds that support essential services throughout the country.” (Larson, 6/24)

Axios: Trump Admin Cuts Contracts With Scientific Publishing Giant

The Trump administration has terminated millions worth of funding for Springer Nature, a German-owned scientific publishing giant that has long received payments for subscriptions from National Institutes of Health and other agencies, Axios has learned. (Bettelheim and Reed, 6/25)

The New York Times: The Evolution Of Trump’s Views On Foreign Aid

Foreign aid, a pillar of American foreign policy for generations, has been gutted since President Trump began his second term in office. The United States Agency for International Development and other government agencies that provide food, medical care and economic development assistance to the world’s poorest nations, have been largely defunded or eliminated in recent months. In justifying the administration’s destruction of the agency, Mr. Trump said U.S.A.I.D. had been run by “radical lunatics,” and he has made numerous false claims about the agency’s work in the developing world. (Jacobs, Datar and de Luca, 6/25)

In related news about the opioid crisis —

Colorado Public Radio: $3 Million From Colorado's Opioid Settlement Haul Will Be Used To Buy Overdose Reversal Kits As Federal Funding Dries Up 

Coloradans will continue to have access statewide to a key medication that reverses overdoses — thanks to a $3 million grant. Attorney General Phil Weiser announced Tuesday that money from Colorado’s opioid settlement haul will go into a statewide fund to buy naloxone, also called Narcan, in bulk. ... Nationally, the Trump administration chopped a massive sum, $11 billion, that was slated to go to states. Colorado was set to receive nearly $230 million of that. (Daley, 6/25)

The New York Times: China Tightens Controls On Fentanyl But Calls It A U.S. Problem

China has strengthened controls on two chemicals that can be used to make fentanyl, its latest step in addressing an issue that has become tangled in its broader trade dispute with the United States. The Trump administration has accused Beijing of not doing enough to stem the flow of fentanyl, a powerful synthetic opioid, into the United States, where it kills tens of thousands of Americans each year. Earlier this year, the administration cited the issue as it imposed tariffs totaling 20 percent on Chinese goods. (Pierson and Bradsher, 6/25)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF